{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:44:10Z","timestamp":1767109450932,"version":"3.30.2"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.gore.2024.101504","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:28:36Z","timestamp":1726727316000},"page":"101504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Androgen receptor expression in recurrent granulosa cell tumor of the ovary: Clinical considerations of treatment and surveillance in a transgender male"],"prefix":"10.1016","volume":"56","author":[{"given":"Jordyn","family":"Tumas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben D.","family":"Alberto Hiraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5165-0570","authenticated-orcid":false,"given":"Tara","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2024.101504_b0005","unstructured":"Aldactone (Spironolactone) [prescribing information]. (2024)."},{"key":"10.1016\/j.gore.2024.101504_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12672-011-0069-3","article-title":"Nuclear receptor profiling of ovarian granulosa cell tumors","volume":"2","author":"Alexiadis","year":"2011","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.gore.2024.101504_b0015","doi-asserted-by":"crossref","first-page":"e220102","DOI":"10.1530\/RAF-22-0102","article-title":"The ovaries of transgender men indicate effects of high dose testosterone on the primordial and early growing follicle pool","volume":"4","author":"Bailie","year":"2023","journal-title":"Reprod. Fertil."},{"key":"10.1016\/j.gore.2024.101504_b0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2021.07.024","article-title":"A phase 2 study of anastrozole in patients with oestrogen receptor and\/progesterone receptor positive recurrent\/metastatic granulosa cell tumours\/sex-cord stromal tumours of the ovary: The PARAGON\/ANZGOG 0903 trial","volume":"163","author":"Banerjee","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101504_b0030","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.2021.15731","article-title":"USPSTF approach to addressing sex and gender when making recommendations for clinical preventive services","volume":"326","author":"Caughey","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.gore.2024.101504_b0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1477-7819-10-85","article-title":"A late recurring and easily forgotten tumor: ovarian granulosa cell tumor","volume":"10","author":"Chen","year":"2012","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.gore.2024.101504_b0040","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.3390\/ijms22147748","article-title":"Androgen\/androgen receptor signaling in ovarian cancer: molecular regulation and therapeutic potentials","volume":"22","author":"Chung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"724","key":"10.1016\/j.gore.2024.101504_b0055","first-page":"e1","article-title":"Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors","volume":"228","author":"Foster","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2024.101504_b0060","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s12094-023-03085-w","article-title":"Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011\u201303","volume":"25","author":"Garcia-Donas","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.gore.2024.101504_b0065","article-title":"The role of androgen hormones in early follicular development","volume":"2014","author":"Gerv\u00e1sio","year":"2014","journal-title":"ISRN Obstet. Gynecol."},{"key":"10.1016\/j.gore.2024.101504_b0070","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/trgh.2021.0061","article-title":"The Comparison of gender dysphoria, body image satisfaction and quality of life between treatment-naive transgender males with and without polycystic ovary syndrome","volume":"7","author":"Gezer","year":"2022","journal-title":"Transgender Heal."},{"key":"10.1016\/j.gore.2024.101504_b0075","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMcp1008161","article-title":"Care of transsexual persons","volume":"364","author":"Gooren","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gore.2024.101504_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.NPR.0000520423.83910.e2","article-title":"Pelvic pain in transgender men taking testosterone: assessing the risk of ovarian cancer","volume":"42","author":"Harris","year":"2017","journal-title":"Nurse Pr."},{"key":"10.1016\/j.gore.2024.101504_b0085","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gore.2024.101504_b0090","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humrep\/des385","article-title":"Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology","volume":"28","author":"Ikeda","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gore.2024.101504_b0095","article-title":"Juvenile granulosa cell tumor in a transgender male with Ollier disease: A case report","volume":"49","author":"Ing","year":"2023","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.gore.2024.101504_b0105","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1159\/000510810","article-title":"Gender dysphoria disrupting the course of treatment of a recurrent juvenile granulosa cell tumor in an adolescent female: a case report","volume":"13","author":"Kwiatkowska","year":"2020","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.gore.2024.101504_b0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2105\/AJPH.2016.303578a","article-title":"Transgender population size in the United States: a meta-regression of population-based probability samples","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Am. J. Public Heal."},{"key":"10.1016\/j.gore.2024.101504_b0115","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ijgc-2018-000065","article-title":"Emerging biomarkers in ovarian granulosa cell tumors","volume":"29","author":"Mills","year":"2018","journal-title":"Int. J. Gynecol. Cancer : off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.gore.2024.101504_b0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jpag.2023.06.007","article-title":"Atypical presentation of granulosa cell tumor in an adolescent: a case report","volume":"36","author":"Morrison","year":"2023","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.gore.2024.101504_b0125","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer V.2.2024. Preprint at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf."},{"key":"10.1016\/j.gore.2024.101504_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2007.08.007","article-title":"Granulosa cell tumor of the ovary","volume":"34","author":"Pectasides","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.gore.2024.101504_b0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.fertnstert.2021.07.1206","article-title":"Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men","volume":"116","author":"Pirtea","year":"2021","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gore.2024.101504_b0140","doi-asserted-by":"crossref","first-page":"e0299373","DOI":"10.1371\/journal.pone.0299373","article-title":"Health status of transgender people globally: A systematic review of research on disease burden and correlates","volume":"19","author":"Scheim","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.gore.2024.101504_b0145","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1200\/JCO.2003.10.019","article-title":"Granulosa cell tumor of the ovary","volume":"21","author":"Schumer","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2024.101504_b0150","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ygyno.2020.09.038","article-title":"Clinical needs for transgender men in the gynecologic oncology setting","volume":"159","author":"Stenzel","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101504_b0155","doi-asserted-by":"crossref","first-page":"2771785","DOI":"10.21037\/tau-20-954","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"9","author":"Sterling","year":"2020","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.gore.2024.101504_b0160","article-title":"A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor","volume":"44","author":"Summey","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.gore.2024.101504_b0165","unstructured":"The Guide to Clinical Preventive Services 2014: Recommendations of the U.S. Preventive Services Task Force. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK235846\/ (2014)."},{"key":"10.1016\/j.gore.2024.101504_b0170","doi-asserted-by":"crossref","first-page":"1093273","DOI":"10.3389\/fendo.2023.1093273","article-title":"Ovarian juvenile granulosa cell tumors with Ollier\u2019s disease in children with IDH1 gene somatic mutation","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:03:25Z","timestamp":1734048205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"alternative-id":["S2352578924001838"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101504","relation":{},"ISSN":["2352-5789"],"issn-type":[{"type":"print","value":"2352-5789"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor expression in recurrent granulosa cell tumor of the ovary: Clinical considerations of treatment and surveillance in a transgender male","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101504"}}